Avadel Meets Revised Target Enrollment for Once-nightly Sodium Oxybate Phase 3 Study for Narcolepsy
Avadel Pharmaceuticals plc, a company focused on developing FT218, an investigational once-nightly...
Read MoreAvadel Pharmaceuticals plc, a company focused on developing FT218, an investigational once-nightly...
Read MoreCollege life can be rigorous and exhausting, but new research suggests that just one extra hour of...
Read MorePopular Science discusses a new study that suggests cerebrospinal fluid helps wash the brain of waste during sleep. However, they didn’t directly measure the rate at which toxins were fleeing the scene—so this study...
Read MoreSeveral studies report a strong link between insomnia and the severity of autism spectrum disorder (ASD)-related symptoms, including social impairment, communication difficulties, and anxiety. Insomnia’s impact on children...
Read MoreUAVenture Capital Fund (UAVC), a venture capital fund dedicated to the commercialization of University of Arizona discoveries, products, technologies, and services, has invested in StimAire Inc. StimAire is developing a...
Read More